CDKN2B-AS1 and coronary artery disorder: Conservatively speaking, it seems possible that Chr9p21 CAD risk genotypes affects genomic expression both in cis and in trans, and linear ANRIL RNA may be one, but not the sole, important effector molecule for how the Chr9p21 locus transduces such effects (Figure 1B).